(Q61956791)
Statements
A Randomised, Double-blind, Placebo-controlled, Dose-escalation, Parallel-group, Single and Multiple Dosing Trial of NN90-1170 in Healthy Volunteers and Patients With Type 2 Diabetes to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics (English)
0 references
August 1999
0 references
November 1999
0 references
24
0 references
18 year
0 references
70 year
0 references